15
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T23521 |
VULM 1457
|
Acyltransferase | Metabolism |
VULM 1457 是有效的胆固醇酰基转移酶抑制剂,具有显著的降血脂活性,并改善了整体心肌缺血再灌注损伤结果。VULM 1457 显著降低肾上腺髓质素的产生和分泌,并下调人肝母细胞上的 AM 受体。VULM 1457 具有研究糖尿病和高胆固醇血症的潜力。 | |||
T4113 |
NBQX
二羟基喹酮,FG9202,NBQX disodium salt |
GluR; iGluR | Membrane transporter/Ion channel; Neuroscience |
NBQX (FG9202) 是强效、选择性和竞争性 AMPA 受体拮抗剂,具有神经保护和抗惊厥活性。 | |||
T6547 |
Ipratropium Bromide
Sch 1000,异丙托溴铵,Itrop,Atrovent |
AChR | Neuroscience |
Ipratropium Bromide (Sch 1000) 是毒蕈碱的受体的拮抗剂,可用于 COPD 和哮喘等研究,对 M1、M2 和 M3 受体的结合的IC50值分别为 2.9、2 和 1.7 nM。 | |||
T2171 |
SEW2871
SEW2871 |
S1P Receptor; LPL Receptor | GPCR/G Protein |
SEW 2871 是一种可口服的高选择性 S1P1激动剂,EC50为 13.8 nM。它减少血液中的淋巴细胞数量,可用于糖尿病、阿尔茨海默氏病、肝纤维化和炎症相关研究。它激活 ERK、Akt 和 Rac 信号通路,并诱导 S1P1 内在化和再循环。 | |||
T0098 |
Ipratropium bromide monohydrate
Ipratropium bromide hydrate,溴化异丙托品单水合物 |
AChR | Neuroscience |
Ipratropium bromide monohydrate (Ipratropium bromide hydrate) 是一种毒蕈碱拮抗剂,结构上与阿托品相关,但它通常被认为对吸入使用更安全、更有效。它用于各种支气管疾病、鼻炎和抗心律失常。 | |||
T6625 |
Ozagrel hydrochloride
Ozagrel HCl,盐酸奥扎格雷,OKY-046 HCl |
Thrombin; Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation; Proteases/Proteasome |
Ozagrel hydrochloride (OKY-046 HCl) 是一种选择性血栓素 A(2) 合成酶抑制剂,用于改善术后脑血管收缩和伴随的脑缺血。它是一种抗血小板剂,可选择性抑制人血小板聚集,IC50为 53.12 μM。 | |||
T6236 |
Ozagrel
奥扎格雷,OKY-046,Domenan |
Thrombin; Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation; Proteases/Proteasome |
Ozagrel (Domenan) 是血栓烷 A2(TXA2) 合酶抑制剂,可抑制哮喘。它也是一种抗血小板剂,可选择性抑制人血小板聚集,IC50为 53.12 μM。 | |||
T26875 |
BN 50739
BN50739,BN-50739 |
||
BN 50739 is an antagonist of platelet-activating factor (PAF). BN 50739 suppresses certain cardiac arrhythmias. PAF is released from ischaemic myocardium and may contribute to initiation of ischaemia-induced ventricular fibrillation (VF) | |||
T27897 |
LY 215490
LY215490,LY-215490 |
||
LY 215490 is a selective, competitive and systemically active antagonist of AMPA receptor. LY 215490 has neuroprotective effect against focal ischaemia in a model of permanent MCA occlusion in the rat. | |||
T25934 |
Pentisomide
Pentisomidum |
||
Pentisomide 是一种抗心律失常的化合物,对去极化(Ia 和 Ic 类作用)和复极有显著作用。它可剂量依赖性地抑制缺血再灌注心律失常。Pentisomide 已进入治疗心律失常的 II 期临床试验。 | |||
T16292 |
NFPS
|
Thrombin | Proteases/Proteasome |
NFPS exerts neuroprotection via glyR alpha1 subunit in the rat model of transient focal cerebral ischaemia and reperfusion. NFPS is a selective and non-competitive glycine transporter-1 (GlyT1) inhibitor (IC50s: 2.8 nM and 9.8 nM for hGlyT1 and rGlyT1, respectively). | |||
T62924 |
Ifetroban sodium
|
||
Ifetroban (BMS-180291) sodium 是一种口服具有活力的血栓素 A2 (TXA2) 或前列腺素 H2 (PGH2) 受体拮抗剂。Ifetroban sodium 表现出抗血小板活性,能够抑制肿瘤细胞迁移,且对细胞增殖无影响。Ifetroban sodium 能够用于研究心肌缺血、中风、高血压、血栓、心肌病。 | |||
T63035 |
Izilendustat hydrochloride
|
||
Izilendustat (hydrochloride) 是一种脯氨酰羟化酶 (prolyl hydroxylase) 的有效抑制剂,能够稳定缺氧诱导因子-1 α (HIF-1α) 和缺氧诱导因子-2 (HIF-2)。Izilendustat (hydrochloride) 具有潜力进行 HIF-1α 相关疾病的研究(包括外周血管疾病(PVD)、心力衰竭、冠状动脉疾病(CAD)、缺血、贫血、结肠炎和其他炎症性肠病)。 | |||
T69806 |
EGIS-8332
|
||
EGIS-8332 is a potent and selective non-competitive AMPA receptor antagonist. EGIS-8332 inhibits AMPA/kainate ion channels and cell death. EGIS-8332 inhibited AMPA currents in rat cerebellar Purkinje cells and inhibited the AMPA- and quisqualate-induced excitotoxicity in primary cultures of telencephalon neurons (IC(50)=5.1-9.0 microM), in vitro. EGIS-8332 seems suitable for further development for the treatment of epilepsy, ischaemia and stroke based on its efficacy in a variety of experimenta... | |||
T71827 |
AG-205
|
||
(rac)-AG-205 是一种对孕激素受体膜组分1 (Pgrmc1) 的有效抑制剂,并能诱导参与甾醇合成的基因表达,这些基因涉及 INSIG1 蛋白与 PGRMC1 形成复合物的过程。(rac)-AG-205 能够抑制 NF-kB 信号及 BDNF/PI3K/AKT 通路的活化,从而防止神经元对缺氧缺血状况的抵抗。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN1875 |
Liriodenine
鹅掌揪碱 |
BCL; Caspase; p53 | Apoptosis; Proteases/Proteasome |
Liriodenine is a potent inhibitor of topoisomerase II (EC 5.99.1.3) both in vivo and in vitro, it has antitumor, antibacterial and antifungal activities, it can suppress ventricular arrhythmias induced by myocardial ischaemia reperfusion, through inhibiti |